Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Methylprednisolone Administration on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group

NCT06623370 is registered in ClinicalTrials.gov with Konya City Hospital as lead sponsor.

NCT NCT06623370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06623370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Methylprednisolone Administration on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group
Lead sponsor
Konya City Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2024
Completion date
January 20, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle weakness, sugammadex reversal time